Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Preveceutical Medical Inc PRVCF


Primary Symbol: C.PREV

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).


CSE:PREV - Post by User

Preveceutical Medical Inc > Buyout potential?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(135)
•••
Comment by Walter333on Jan 11, 2022 10:27pm
232 Views
Post# 34306549

RE:RE:RE:Buyout potential?

RE:RE:RE:Buyout potential?
BizarroJerry1 wrote:
Hey you're making me want to double down when it hits 2 again. One thing I've noticed is how resilient this stock is to market shock.


Simply my personal opinion. A Google search will lead you to the product agreement between Asterion and Preveceutical, Bridgemark, what miRNA and siRNA are and the differences between them and uses thereof. The recent surge in volume would indicate investors are once again loading TFSA's imo. Do not mean to persuade in any way, all in my opinion based off information pieced together and collected over the years. Could be dead on, or farthest thing from the truth. Only time will tell. Again good luck to you in your investments and trades.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities